Regeneron Pharm (NASDAQ:REGN) traded in a range yesterday that spanned from a low of $315.60 to a high of $322.69. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $317.63 on volume of 212,000 …
Yet, there it is. REGN shares popped more than 6% on Tuesday, following an almost defiant call from Piper Jaffrey analyst Ed Tenthoff, who thinks REGN stock is worth 11% more than its current price even with Tuesday’s big gain. There’s no …
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stock has been a huge winner in the past. A $10,000 investment in the biotech 10 years ago would be worth more than $200,000 today. Regeneron's shareholders have been on a roller …
Regeneron (NASDAQ: REGN) CEO Leonard Schleifer was on the hot seat Monday at the Morgan Stanley healthcare conference. And the timing was either terrific or terrible, depending on your perspective. Regeneron stock opened more …